narmac, I agree overall, and I do believe the molecule will make it to market, someday, somehow. But at what cost, time-frame, in what partnership, and how? 

The finances are a MUCH bigger concern now though, to me, than previously. Even though we were "apparently" running on fumes, we were just trying to get to the BoM finish line with positive TLD for a cornucopia of options to open up thereafter ...

A lot murkier now, with a bottomed out pps, thin/empty coffers, plus HUGE expenses and time ahead to get something to market (3-5 years best case?) .....

..... UNLESS - there is enough FLD positivity in one form or another to either proceed with an apabetalone NDA in the near term for Cardio? ... or enough STRONG promise for the next round of P3's (Cardio, Renal, Cognitive) to attract another large whale (or get more from current whales) ..... so that we can either get thru an NDA financially now, or proceed with the next P3's that will be needed and require time, and LOTS of dough for payroll, travel, other expenses, etc.

I am still VERY hopeful in the long term, "somewhat" hopeful in the short term (FLD?), but feeling very tenous about RVX pending FLD ..... FLD is gonna determine a lot with regard to the future, goals, operations, finances, and possibly even existence (as we know it)

JMHO's with what I know as a mushroom, hopefully the RVX braintrust already knows a helluva lot more about the data, and their current & future parnership opportunities, and leverage.

Still longggggg ... especially on the science and long term opportunity ... but VERY concerned about RVX stability and viability (till I learn more about finances and FLD).

Again, a "mushroom" investor here, and JMHO ...